anthem glp-1 coverage 2025 Blue Cross Blue Shield Drops of Obesity Drugs How Employers Can Manage GLP-1

The oral formulation is the most significant differentiator: if an oral tablet can produce weight loss comparable to injectable CagriSema, it could fundamentally change how dual pathway obesity therapy is delivered

Its a reflection of whats happening deeper within your skin and, often, your body

Deoxycholic acid breaks down the fat cells over time and helps the body absorb fat

CPT 96374, by contrast, covers intravenous (IV) push administration where the substance is delivered directly into a vein, typically by a syringe, and the administering provider must be present during the entire infusion

Genetic context, combined with biomarker data (fasting glucose, insulin levels, lipid profiles) and clinical history, enables precision-wellness decision-making rather than one-size-fits-all recommendations